FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Teva Pharmaceuticals Qnasl Recall

Qnasl (beclomethasone dipropionate) Nasal Aerosol, 80 mcg per spray, 120 metered sprays, 8

Teva Pharmaceuticals USA · Horsham, PA

Risk level
Class III
Reported by FDA
Jan 1, 2014
Recall ID
D-382-2014
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Qnasl starting Dec 4, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-382-2014 on Jan 1, 2014. Reason: Defective Delivery System: There is a potential for some units in certain lots of Qnasl Nasal Aerosol 80 mcg metered spray to have clogged stem valves. Status: Terminated.

Why it was recalled

Defective Delivery System: There is a potential for some units in certain lots of Qnasl Nasal Aerosol 80 mcg metered spray to have clogged stem valves.

Product description

Qnasl (beclomethasone dipropionate) Nasal Aerosol, 80 mcg per spray, 120 metered sprays, 8.7 g inhaler, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044; By: 3M Delivery Systems, Northridge, CA 91324, NDC 59310-210-12, UPC 3 59310 21012 9.

Lot numbers, UPCs & expiration codes

Lot #: 120004, Exp 01/14; 120095, 120131, 120131 2, Exp 03/14; 120271, Exp 07/14; 120351, Exp 08/14

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-382-2014
Classification
Class III
Status
Terminated
Recall initiated
Dec 4, 2013
FDA report date
Jan 1, 2014
Quantity
379,463 inhalers
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA

Original FDA data

Every field from FDA enforcement report D-382-2014, exactly as published.

Show all FDA fields
City
Horsham
State
PA
Status
Terminated
Country
United States
Event ID
67010
Address
425 Privet Rd
Code information
Lot #: 120004, Exp 01/14; 120095, 120131, 120131 2, Exp 03/14; 120271, Exp 07/14; 120351, Exp 08/14
Postal code
19044-1220
Report date
Jan 1, 2014
Product type
Drugs
Recall number
D-382-2014
Classification
Class III
Recalling firm
Teva Pharmaceuticals USA
Product quantity
379,463 inhalers
Termination date
Aug 27, 2014
Reason for recall
Defective Delivery System: There is a potential for some units in certain lots of Qnasl Nasal Aerosol 80 mcg metered spray to have clogged stem valves.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Qnasl (beclomethasone dipropionate) Nasal Aerosol, 80 mcg per spray, 120 metered sprays, 8.7 g inhaler, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044; By: 3M Delivery Systems, Northridge, CA 91324, NDC 59310-210-12, UPC 3 59310 21012 9.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Dec 4, 2013
Initial firm notification
Letter
Center classification date
Dec 20, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-382-2014, published Jan 1, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls